These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21575258)

  • 101. Comprehensive network of miRNA-induced intergenic interactions and a biological role of its core in cancer.
    Galatenko VV; Galatenko AV; Samatov TR; Turchinovich AA; Shkurnikov MY; Makarova JA; Tonevitsky AG
    Sci Rep; 2018 Feb; 8(1):2418. PubMed ID: 29402894
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy.
    Jordan EJ; Basturk O; Shia J; Klimstra DS; Alago W; D'Angelica MI; Abou-Alfa GK; O'Reilly EM; Lowery MA
    J Gastrointest Oncol; 2017 Oct; 8(5):E65-E72. PubMed ID: 29184698
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Exome and transcriptome sequencing identifies loss of
    Oh BY; Cho J; Hong HK; Bae JS; Park WY; Joung JG; Cho YB
    Cancer Manag Res; 2017; 9():581-589. PubMed ID: 29184442
    [TBL] [Abstract][Full Text] [Related]  

  • 104. miR-141 promotes colon cancer cell proliferation by inhibiting MAP2K4.
    Ding L; Yu LL; Han N; Zhang BT
    Oncol Lett; 2017 Mar; 13(3):1665-1671. PubMed ID: 28454307
    [TBL] [Abstract][Full Text] [Related]  

  • 105. MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4.
    Wu X; Gong Z; Sun L; Ma L; Wang Q
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28319306
    [TBL] [Abstract][Full Text] [Related]  

  • 106. An exact algorithm for finding cancer driver somatic genome alterations: the weighted mutually exclusive maximum set cover problem.
    Lu S; Mandava G; Yan G; Lu X
    Algorithms Mol Biol; 2016; 11():11. PubMed ID: 27148394
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Registered report: Diverse somatic mutation patterns and pathway alterations in human cancers.
    Sharma V; Young L; Allison AB; Owen K; ;
    Elife; 2016 Feb; 5():. PubMed ID: 26894955
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Revealing the Complexity of Breast Cancer by Next Generation Sequencing.
    Verigos J; Magklara A
    Cancers (Basel); 2015 Nov; 7(4):2183-200. PubMed ID: 26561834
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Loss of heterozygosity: what is it good for?
    Ryland GL; Doyle MA; Goode D; Boyle SE; Choong DY; Rowley SM; Li J; ; Bowtell DD; Tothill RW; Campbell IG; Gorringe KL
    BMC Med Genomics; 2015 Aug; 8():45. PubMed ID: 26231170
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Evaluation and integration of cancer gene classifiers: identification and ranking of plausible drivers.
    Liu Y; Tian F; Hu Z; DeLisi C
    Sci Rep; 2015 May; 5():10204. PubMed ID: 25961669
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Mining TCGA data using Boolean implications.
    Sinha S; Tsang EK; Zeng H; Meister M; Dill DL
    PLoS One; 2014; 9(7):e102119. PubMed ID: 25054200
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer.
    Gorringe KL; Choong DY; Williams LH; Ramakrishna M; Sridhar A; Qiu W; Bearfoot JL; Campbell IG
    Neoplasia; 2008 Nov; 10(11):1253-8. PubMed ID: 18953434
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer.
    Davis SJ; Choong DY; Ramakrishna M; Ryland GL; Campbell IG; Gorringe KL
    BMC Cancer; 2011 May; 11():173. PubMed ID: 21575258
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
    Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
    Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
    [TBL] [Abstract][Full Text] [Related]  

  • 115. p16/MTS1 inactivation in ovarian carcinomas: high frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors.
    Milde-Langosch K; Ocon E; Becker G; Löning T
    Int J Cancer; 1998 Feb; 79(1):61-5. PubMed ID: 9495360
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression.
    Ahn YH; Yang Y; Gibbons DL; Creighton CJ; Yang F; Wistuba II; Lin W; Thilaganathan N; Alvarez CA; Roybal J; Goldsmith EJ; Tournier C; Kurie JM
    Mol Cell Biol; 2011 Nov; 31(21):4270-85. PubMed ID: 21896780
    [TBL] [Abstract][Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.